View EO 12866 Meeting 0910-AI31

  Drug Products or Categories of Drug Products That Present Demonstrable Difficulties for Compounding Under Sections 503A or 503B of the Federal Food, Drug, and Cosmetic Act


  Proposed Rule Stage

  09/19/2023 03:30 PM

  American Pharmacists Association   Michael Baxter   Compounding Core Group

List of Documents
OMB Call Summary APhA Compounding Core Group
List of Attendees Participation
•   Dr. Natalie Young  - APhA Compounding Core Group Chair Teleconference 
•   Dr. Matt Martin  - APhA Compounding Core Group Chair-Elect Teleconference 
•   Dr. Ilisa Bernstein  - American Pharmacists Association Teleconference 
•   Michael Baxter  - American Pharmacists Association Teleconference 
•   Julie Wise  - OMB Teleconference 
•   Jane Wargo  - HHS Teleconference 
•   Megan Anderson  - FDA Teleconference 
•   Sara Rothman  - FDA Teleconference 
•   Kathleen Anderson  - FDA Teleconference 
•   Aaron Young  - FDA Teleconference 
•   Emily Galloway  - FDA Teleconference 
•   Gabrielle Cosel  - FDA Teleconference 
•   Jean McCue  - FDA Teleconference 
•   Nikki Kofsky  - FDA Teleconference 
•   Nnaemeka Chukwudebe  - FDA Teleconference